205 related articles for article (PubMed ID: 36247875)
1. Comprehensive Analysis of the Role of
Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C
Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875
[TBL] [Abstract][Full Text] [Related]
2. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
Zhang S; Yu S; Wang J; Cheng Z
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma.
Li B
Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344
[TBL] [Abstract][Full Text] [Related]
4. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
5. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
6. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
[TBL] [Abstract][Full Text] [Related]
7. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
[TBL] [Abstract][Full Text] [Related]
8.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
11. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
12. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
13. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.
Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F
Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382
[TBL] [Abstract][Full Text] [Related]
16. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma.
Xu B; Wang R; Zhang J; Wang L; Cui X; Chai F; Du X; Jiang Y
Endokrynol Pol; 2023; 74(3):315-330. PubMed ID: 37695034
[TBL] [Abstract][Full Text] [Related]
18.
Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer.
Yu M; Qian XX; Li G; Cheng Z; Lin Z
World J Surg Oncol; 2022 Jul; 20(1):243. PubMed ID: 35902909
[TBL] [Abstract][Full Text] [Related]
20. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
